Barr Shifts Roles At The Top, Splits Up Senior Management Duties
This article was originally published in The Pink Sheet Daily
Executive Summary
Restructure frees CEO Downey of responsibilities he assumed when Bisaro jumped to Watson in August.
You may also be interested in...
Teva’s Acquisition Of Barr Will Boost Research For Molecules Large And Small
Teva expects to double its R&D capabilities with the acquisition of Barr, executives from both firms said during a July 21 luncheon in New York
Teva’s Acquisition Of Barr Will Boost Research For Molecules Large And Small
Teva expects to double its R&D capabilities with the acquisition of Barr, executives from both firms said during a July 21 luncheon in New York
Watson Snags Barr’s Bisaro For CEO Role
Exec, who has been with Barr since 1992, was key part of firm's Pliva acquisition.